168 related articles for article (PubMed ID: 27473338)
1. The Influence of Human Interindividual Variability on the Low-Dose Region of Dose-Response Curve Induced by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Primary B Cells.
Dornbos P; Crawford RB; Kaminski NE; Hession SL; LaPres JJ
Toxicol Sci; 2016 Oct; 153(2):352-60. PubMed ID: 27473338
[TBL] [Abstract][Full Text] [Related]
2. Induction of the aryl hydrocarbon receptor-responsive genes and modulation of the immunoglobulin M response by 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary human B cells.
Lu H; Crawford RB; Suarez-Martinez JE; Kaplan BL; Kaminski NE
Toxicol Sci; 2010 Nov; 118(1):86-97. PubMed ID: 20702590
[TBL] [Abstract][Full Text] [Related]
3. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated disruption of the CD40 ligand-induced activation of primary human B cells.
Lu H; Crawford RB; Kaplan BL; Kaminski NE
Toxicol Appl Pharmacol; 2011 Sep; 255(3):251-60. PubMed ID: 21807014
[TBL] [Abstract][Full Text] [Related]
4. Characterizing Serpinb2 as a Modulator of TCDD-Induced Suppression of the B Cell.
Dornbos P; Warren M; Crawford RB; Kaminski NE; Threadgill DW; LaPres JJ
Chem Res Toxicol; 2018 Nov; 31(11):1248-1259. PubMed ID: 30339366
[TBL] [Abstract][Full Text] [Related]
5. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
Phadnis-Moghe AS; Crawford RB; Kaminski NE
Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051
[TBL] [Abstract][Full Text] [Related]
6. Suppression of the IgM Response by Aryl Hydrocarbon Receptor Activation in Human Primary B Cells Involves Impairment of Immunoglobulin Secretory Processes.
Zhou J; Henriquez J; Crawford R; Kaminski N
Toxicol Sci; 2018 May; 163(1):319-329. PubMed ID: 29462421
[TBL] [Abstract][Full Text] [Related]
7. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.
Karras JG; Morris DL; Matulka RA; Kramer CM; Holsapple MP
Toxicol Appl Pharmacol; 1996 Apr; 137(2):275-84. PubMed ID: 8661353
[TBL] [Abstract][Full Text] [Related]
8. TCDD-mediated suppression of naïve human B cell IgM secretion involves aryl hydrocarbon receptor-mediated reduction in STAT3 serine 727 phosphorylation and is restored by interferon-γ.
Blevins LK; Zhou J; Crawford R; Kaminski NE
Cell Signal; 2020 Jan; 65():109447. PubMed ID: 31678681
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
Sulentic CE; Holsapple MP; Kaminski NE
Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
[TBL] [Abstract][Full Text] [Related]
10. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
Sulentic CE; Holsapple MP; Kaminski NE
J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
[TBL] [Abstract][Full Text] [Related]
11. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells.
Crawford RB; Sulentic CE; Yoo BS; Kaminski NE
Toxicol Sci; 2003 Oct; 75(2):333-42. PubMed ID: 12883080
[TBL] [Abstract][Full Text] [Related]
12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Karras JG; Holsapple MP
Toxicol Appl Pharmacol; 1994 Apr; 125(2):264-70. PubMed ID: 8171434
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte-Specific Protein Tyrosine Kinase (LCK) is Involved in the Aryl Hydrocarbon Receptor-Mediated Impairment of Immunoglobulin Secretion in Human Primary B Cells.
Zhou J; Zhang Q; Henriquez JE; Crawford RB; Kaminski NE
Toxicol Sci; 2018 Oct; 165(2):322-334. PubMed ID: 29860352
[TBL] [Abstract][Full Text] [Related]
15. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.
North CM; Crawford RB; Lu H; Kaminski NE
Toxicol Sci; 2010 Jul; 116(1):99-112. PubMed ID: 20348231
[TBL] [Abstract][Full Text] [Related]
16. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity: II. B cell activation.
Morris DL; Holsapple MP
Immunopharmacology; 1991; 21(3):171-81. PubMed ID: 1917439
[TBL] [Abstract][Full Text] [Related]
17. Immunological characterization of the aryl hydrocarbon receptor (AHR) knockout rat in the presence and absence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Phadnis-Moghe AS; Chen W; Li J; Crawford RB; Bach A; D'Ingillo S; Kovalova N; Suarez-Martinez JE; Kaplan BL; Harrill JA; Budinsky R; Rowlands JC; Thomas RS; Kaminski NE
Toxicology; 2016 Aug; 368-369():172-182. PubMed ID: 27590929
[TBL] [Abstract][Full Text] [Related]
18. Developmental exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin attenuates capacity of hematopoietic stem cells to undergo lymphocyte differentiation.
Ahrenhoerster LS; Tate ER; Lakatos PA; Wang X; Laiosa MD
Toxicol Appl Pharmacol; 2014 Jun; 277(2):172-82. PubMed ID: 24709672
[TBL] [Abstract][Full Text] [Related]
19. All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Zhang Q; Kline DE; Bhattacharya S; Crawford RB; Conolly RB; Thomas RS; Andersen ME; Kaminski NE
Toxicol Appl Pharmacol; 2013 Apr; 268(1):17-26. PubMed ID: 23357550
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs human B lymphopoiesis.
Li J; Phadnis-Moghe AS; Crawford RB; Kaminski NE
Toxicology; 2017 Mar; 378():17-24. PubMed ID: 28049042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]